AUSTIN, Texas - August 26, 2025 – BetterWay™ blood testing by Babson Diagnostics today announced the addition of six important offerings to its menu: an Iron Panel (consisting of four tests), Cortisol, and Quantitative hCG Pregnancy. With these additions, BetterWay now offers 67 commonly ordered tests, continuing its mission to provide affordable, accessible, and reliable blood testing.
The expanded menu brings unique value to patients. The new Quantitative hCG Pregnancy test—the same blood test ordered by doctors to confirm pregnancy—offers several advantages over traditional at-home tests:
-
Offers a convenient, affordable alternative to multiple at-home tests
-
Provides the same quantitative test ordered by doctors
-
Enables confirmation of pregnancy sooner, helping patients and clinicians make timely health decisions
The Iron Panel supports detection and management of iron-related health conditions, while the Cortisol test provides insights into stress and adrenal function. As with all BetterWay tests, samples require only a pea-sized drop of blood collected from a fingertip at convenient clinical and retail locations.
“Women do not want to wait six weeks to get an hCG pregnancy test, so our new test menu is going to considerably improve convenience for them,” said David Stein, Babson’s CEO. “All of our tests, including the ones we launched today, put the patient first by offering quality, convenience, and affordability.”
BetterWay blood testing makes blood collection less invasive and more convenient without sacrificing the accuracy and efficiency of laboratory testing. Samples are analyzed at Babson’s CLIA-certified lab in Austin, and customers receive test results in one to two days. The company partners with retailers, healthcare organizations, clinician practices, and employers to offer their communities access to affordable testing with a preferred experience.
Babson launched BetterWay in May 2024 with a menu of 55 tests, covering the analytes most commonly ordered for routine exams, chronic condition management, and screenings, and has continued to add more tests since then. The addition of these six offerings—bringing the total to 67 tests—further expands access to vital health insights and reaffirms BetterWay’s position as a leader in patient-centered blood testing.
For more details, visit BetterWay.com or follow us on Instagram or LinkedIn.
About BetterWay by Babson Diagnostics
BetterWayTM is blood testing reimagined—patient-friendly fingertip collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing. Babson was named 2024 Medtech Company of the Year by MD + DI, 2025 SXSW Innovation Award winner for Health & Biotech, and one of Fast Company’s 2025 Most Innovative Companies in Healthcare. For more information, please visit BetterWay.com or connect with us on Instagram or LinkedIn.
Media inquiries only:
Ray Young
512.694.6097
For general inquiries: discover@babsondx.com
